Agespan, a platform for data-driven personalised medicine

Fight cruel diseases, before they happen

A Digital twin

Obtain every possible risks and understand your patients with a whole new degree of complexity with our digital twins. We build digital replicas from our holistic analyses that can be analyzed, manipulated, and tested.

 

Help decision

Test the potential of medications against all potential comorbidity Simulate the effects of different treatments on a patient, enabling tailored treatments based on individual needs, reducing side effects and improving outcomes.

Support diagnosis

Dynamically engage with our platform to pinpoint all potential sources behind your observations.  By providing a comprehensive view of the patient’s biology, our models can help decision-makers to take more informed choices based on accurate simulations and real-time data.

Empower everyone

Our reports empower individuals to take better care of their health by providing personalized insights, enhancing understanding of their bodies, and enabling proactive management of their well-being.

Predict risks, understand why

Combining the analysis of multiple hallmarks of ageing, our model can predict disease risks and their possible onsets.

PueroVita generate personalised health reports based on these risks, empowering individuals to improve their health and ageing.

Follow-up development

Patients can re-take non-genetic elements of our tests to follow the effects of our recommandations. We track how epigenetic, inflammation or brain age evolve, and refine risk predictions.

Refine diagnosis

Interact with our platform to check if our models identified risks in concordance with your diagnosis.

By integrating diverse data sources and leveraging AI’s powerful analytical potential, the platform can identify complex relationships between various ageing markers and health outcomes. This comprehensive understanding enables physicians to make more accurate diagnoses

Test possible medications

The list of comorbidity for drugs and medications can be long.

By harnessing the power of AI and multi-dimensional analysis of ageing markers, the platform can help physicians refine medication strategies, minimize drug interactions, and effectively manage comorbidity, ultimately contributing to more personalized and effective patient care.

The Big idea

We are building the most accurate risk predictions through the integration of multiple hallmarks of ageing with AI.

We use state-of-the-art proprietary ML models to study the holistic interactions of these hallmarks.

Our models are trained on large amounts of data, representing people from everywhere. We believe good health should be available everywhere, for everyone.

Follow our development: we update this page following our scientific development.

  • Genetic 85% 85%
  • Epigenetic 60% 60%
  • Inflammation 20% 20%
  • Mitochondrial dysfunction 10% 10%
  • Drug to gene interactions 60% 60%
  • Stem cell exhaustion 10% 10%
  • Platform development 50% 50%
Learn more about our science